recall
saveFresenius Kabi USA, LLC recall (Cls II)
April 15, 2026updated 5mo ago
community read0 votes
5% Dextrose Injection, USP 2.5 g per 50 mL (50 mg per mL) 50 mL in a 100 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-456-05, Unit of Sale NDC Number: 65219-456-60. — Reason: Lack of Assurance of Sterility — Status: Ongoing
view source ↗Data sources
last refreshed 27m ago
Found something off?
same company · ±60 days · 6
- recallFresenius Kabi USA, LLC recall (Cls II)Apr 15, 2026
- recallFresenius Kabi USA, LLC recall (Cls II)Apr 15, 2026
- recallFresenius Kabi USA, LLC recall (Cls II)Apr 15, 2026
- recallFresenius Kabi USA, LLC recall (Cls II)Apr 15, 2026
- recallFresenius Kabi USA, LLC recall (Cls II)Apr 15, 2026
- recallFresenius Kabi USA, LLC recall (Cls II)Apr 15, 2026
🐶 often sniffed alongside
top 8- tagApproval258 co-mentions · 129 sources
- drugRNS-60236 co-mentions · 149 sources
- drugDIPRIVAN78 co-mentions · 39 sources
- drugPROPOFOL39 co-mentions · 39 sources
- drugDILAUDID-HP38 co-mentions · 19 sources
- tagRecall33 co-mentions · 20 sources
- drughydromorphone hydrochloride ER19 co-mentions · 19 sources
- drugHYDROMORPHONE HYDROCHLORIDE19 co-mentions · 19 sources
comments(0)
5-min edit window · permanent after that